İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025

Acute Disseminated Encephalomyelitis in Children and Adolescents: A Multicenter Retrospective Study of Relapse and Outcome.

Journal of child neurology

YÖKSİS OpenAlex SJR Q2 JCR Q3 Atıf 0 Yüzdelik 11.9% FWCI 0.0
Yıl
2025
ISSN
0883-0738
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Objectives To evaluate the demographic, clinical, laboratory, and prognostic data of children with acute disseminated encephalomyelitis with respect to anti-myelin oligodendrocyte glycoprotein (MOG) antibody status. Methods Acute disseminated encephalomyelitis patients (n = 245) from 24 centers followed up between 2010 and 2022 were evaluated retrospectively. The short- and long-term outcome characteristics (disease severity and course, clinical relapse, and recovery rates) were assessed. Incomplete clinical recovery was defined as modified Rankin Score ≥1 or the presence of epilepsy. Univariant and multivariant analysis were performed for outcome characteristics. Results The mean age at diagnosis was 6.3 ± 3.8 (0.5-17.7) years and the median follow-up was 22 (3-132) months. The outcome characteristics were evaluated in 180 of 245 patients (73.4%) with at least 12 months’ follow-up. Twenty-three patients (12.6%) relapsed. The multivariable logistic regression analysis revealed the following clinical parameters as predictors of relapse: sex, visual impairment, and ataxia at initial presentation. Incomplete clinical recovery (n = 42/180, 23.3%) was associated with the presence of seizures on admission and the need for an intensive care unit. Anti-MOG antibody positivity was not associated with an increased risk of relapse (25% vs 13.1%, P = .164) or incomplete clinical recovery ( P = .511). Conclusion The nationwide cohort presented further supports the typically monophasic nature of acute disseminated encephalomyelitis, and a high rate of complete recovery. The presence of certain symptoms in the acute period may assist the clinician in estimating the outcome.

Konular

  • Multiple Sclerosis Research Studies
  • Bacterial Infections and Vaccines
  • Herpesvirus Infections and Treatments

Birincil konu Multiple Sclerosis Research Studies

Yazarlar

  1. SEDA KANMAZ
  2. sanem yılmaz
  3. NİHAL OLGAÇ DÜNDAR
  4. AYŞE AKSOY
  5. MEHMET CANPOLAT
  6. HÜSEYİN PER
  7. İLKNUR EROL
  8. HAKAN GÜMÜŞ
  9. YASEMİN ÖZKALE
  10. SELCAN ÖZTÜRK
  11. DİLARA ECE ÖZTOPRAK
  12. İBRAHİM HALİL ÖNCEL
  13. MURAT ÖZKALE
  14. ELİF NURDAN ÖZMANSUR
  15. HEPSEN MİNE SERİN
  16. GÜLŞEN ERSÖZ
  17. ŞEYDA BEŞEN
  18. GÜLEN GÜL MERT ÇUKUROVA ÜNİVERSİTESİ
  19. AYTEN GÜLEÇ
  20. SEVİM ŞAHİN
  21. CEMİLE BÜŞRA ÖLÇÜLÜ
  22. AYBERK SELEK
  23. SERDAR PEKUZ
  24. GÜNCE BAŞARIR
  25. ÇAĞATAY GÜNAY
  26. DİDEM BİÇER
  27. ZEHRA FİLİZ KARAMAN
  28. DENİZ YÜKSEL
  29. MERAL KARADAĞ
  30. ERDEM ŞİMŞEK
  31. AYCAN ÜNALP
  32. NİHAL YILDIZ
  33. MELTEM ÇOBANOĞULLARI DİREK
  34. ULUÇ YİŞ
  35. HÜSEYİN TAN
  36. CENGİZ HAVALI
  37. AYDAN DEĞERLİYURT
  38. MESUT GÜNGÖR
  39. MİHRİBAN ÖZLEM HERGÜNER
  40. ELİF PERİHAN ÖNCEL
  41. OLCAY ÜNVER
  42. SEFER KUMANDAŞ
  43. HALE ATALAY ÇELİK
  44. BİLGE ÖZGÖR
  45. ALİ CANSU
  46. AYŞE TOSUN
  47. OLCAY GÜNGÖR
  48. ÇETİN OKUYAZ
  49. SELVİNAZ EDİZER
  50. AYŞE SEMRA HIZ
  51. ESRA SARIGEÇİLİ
  52. HÜLYA KAYILIOĞLU
  53. CEYHUN YAZGAN
  54. GÖKÇEN ÖZ TUNÇER
  55. PINAR GENÇPINAR
  56. ÜNSAL YILMAZ
  57. SAMİ ÖZGÜR
  58. HASAN TEKGÜL
  59. FATMA BANU ANLAR
  60. AYŞE FAHRİYE TOSUN İZMİR TINAZTEPE ÜNİVERSİTESİ